Catalyst Event

WuXi Biologics (Cayman) Inc (2269) · Other

From Akros SCHK HK-Global Brain-Computer Interface Index (ASHGBCI)

4/24/2026, 12:00:00 AM

OtherSentiment: Positive

Announced the completion of the main structure and arrival of key equipment for its new microbial commercial manufacturing site in Chengdu, with GMP production scheduled to begin by the end of 2026; Medium importance justified by capacity expansion likely causing ≥5% price impact.

Korean Translation

청두 미생물 상업 생산 기지의 주요 구조물 완공 및 핵심 장비 반입 발표, 2026년 말 GMP 생산 시작 예정으로 5% 이상의 주가 영향이 예상됨.

Related Recent Events

View Full Timeline